Philip R. Liebson

13.9k total citations · 5 hit papers
96 papers, 10.1k citations indexed

About

Philip R. Liebson is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Philip R. Liebson has authored 96 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Cardiology and Cardiovascular Medicine, 31 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Philip R. Liebson's work include Cardiovascular Function and Risk Factors (37 papers), Cardiac Imaging and Diagnostics (31 papers) and Blood Pressure and Hypertension Studies (31 papers). Philip R. Liebson is often cited by papers focused on Cardiovascular Function and Risk Factors (37 papers), Cardiac Imaging and Diagnostics (31 papers) and Blood Pressure and Hypertension Studies (31 papers). Philip R. Liebson collaborates with scholars based in United States, Finland and Sweden. Philip R. Liebson's co-authors include Ezra A. Amsterdam, Susan J. Zieman, Marc S. Sabatine, Debabrata Mukherjee, Nanette K. Wenger, Hani Jneid, Michael C. Kontos, Eric D. Peterson, Ralph G. Brindis and Théodore G. Ganiats and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Philip R. Liebson

93 papers receiving 9.7k citations

Hit Papers

2014 AHA/ACC Guideline for t... 1991 2026 2002 2014 2014 1991 2014 2014 2014 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
    2014 2.7k citations Ezra A. Amsterdam, Nanette K. Wenger et al. Journal of the American College of Cardiology profile →
  2. Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
    1991 2.1k citations Debra S. Echt, Philip R. Liebson et al. New England Journal of Medicine profile →
  3. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
    2014 901 citations Ezra A. Amsterdam, Nanette K. Wenger et al. Circulation profile →
  4. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
    2014 786 citations Ezra A. Amsterdam, Nanette K. Wenger et al. Circulation profile →
  5. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
    2014 617 citations Ezra A. Amsterdam, Nanette K. Wenger et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip R. Liebson United States 32 8.4k 2.1k 2.1k 792 568 96 10.1k
Kim Fox United Kingdom 51 8.4k 1.0× 2.0k 0.9× 2.6k 1.2× 747 0.9× 396 0.7× 224 10.3k
Susan J. Zieman United States 35 6.5k 0.8× 2.1k 1.0× 1.7k 0.8× 814 1.0× 543 1.0× 62 9.1k
Jaap W. Deckers Netherlands 50 7.4k 0.9× 2.9k 1.4× 2.0k 1.0× 990 1.3× 623 1.1× 201 10.7k
Lars Rydén Sweden 29 8.6k 1.0× 1.7k 0.8× 2.0k 0.9× 1.9k 2.4× 808 1.4× 119 11.0k
Eugene R. Passamani United States 40 6.9k 0.8× 3.9k 1.9× 3.1k 1.5× 609 0.8× 410 0.7× 65 10.2k
Shmuel Gottlieb Israel 32 7.5k 0.9× 3.0k 1.4× 1.1k 0.5× 445 0.6× 440 0.8× 134 8.6k
Bariş Gencer Switzerland 32 6.5k 0.8× 3.7k 1.8× 2.2k 1.1× 1.3k 1.6× 553 1.0× 188 9.9k
Tomas Jernberg Sweden 55 8.9k 1.1× 3.1k 1.5× 2.9k 1.4× 660 0.8× 495 0.9× 331 11.7k
Edward M. Geltman United States 40 7.7k 0.9× 1.7k 0.8× 2.6k 1.2× 902 1.1× 471 0.8× 93 9.7k
Steen Z. Abildstrøm Denmark 36 4.1k 0.5× 1.3k 0.6× 1.3k 0.6× 675 0.9× 392 0.7× 110 6.7k

Countries citing papers authored by Philip R. Liebson

Since Specialization
Citations

This map shows the geographic impact of Philip R. Liebson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip R. Liebson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip R. Liebson more than expected).

Fields of papers citing papers by Philip R. Liebson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip R. Liebson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip R. Liebson. The network helps show where Philip R. Liebson may publish in the future.

Co-authorship network of co-authors of Philip R. Liebson

This figure shows the co-authorship network connecting the top 25 collaborators of Philip R. Liebson. A scholar is included among the top collaborators of Philip R. Liebson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip R. Liebson. Philip R. Liebson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amsterdam, Ezra A., Nanette K. Wenger, Ralph G. Brindis, et al.. (2014). 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes. Circulation. 130(25). e344–426. 786 indexed citations breakdown →
2.
Amsterdam, Ezra A., Nanette K. Wenger, Ralph G. Brindis, et al.. (2014). 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary. Journal of the American College of Cardiology. 64(24). 2645–2687. 617 indexed citations breakdown →
3.
Calvin, James E., et al.. (2011). ECHO ESTIMATES OF PULMONARY ARTERY PRESSURE CORRELATES POORLY WITH RIGHT HEART CATHETERIZATION. Journal of the American College of Cardiology. 57(14). E1572–E1572. 1 indexed citations
4.
Liebson, Philip R.. (2006). Calcium channel blockers in the spectrum of antihypertensive agents. Expert Opinion on Pharmacotherapy. 7(17). 2385–2401. 8 indexed citations
5.
Liebson, Philip R.. (2004). VISP and INVEST. Preventive Cardiology. 7(2). 93–96. 1 indexed citations
6.
Forrester, James S., Philip R. Liebson, Joseph E. Parrillo, & Lloyd W. Klein. (2002). Risk stratification post–myocardial infarction: Is early coronary angiography the more effective strategy?. Progress in Cardiovascular Diseases. 45(1). 49–66. 5 indexed citations
7.
Liebson, Philip R., et al.. (2002). Effect of contrast enhancement on measurement of carotid artery intimal medial thickness. Journal of the American College of Cardiology. 39. 219–219. 2 indexed citations
8.
Liebson, Philip R. & Ezra A. Amsterdam. (2000). Prevention of coronary heart disease. Disease-a-Month. 46(1). 1–123. 6 indexed citations
9.
Liebson, Philip R., et al.. (1999). Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications?. Journal of the American College of Cardiology. 33(1). 107–118. 57 indexed citations
10.
Liebson, Philip R.. (1999). Left ventricular hypertrophy. Current Treatment Options in Cardiovascular Medicine. 1(3). 219–230. 8 indexed citations
11.
Turner, David A., et al.. (1997). Comparison of Cine Magnetic Resonance Imaging and Doppler Echocardiography for Evaluation of Left Ventricular Diastolic Function. The American Journal of Cardiology. 80(3). 384–386. 46 indexed citations
12.
Peters, Robert W., Brent Mitchell, Maria M. Brooks, et al.. (1994). Circadian pattern of arrythmic death in patients receiving encainide, Flecainide or moricizine in the cardiac arrhythmia. Journal of the American College of Cardiology. 23(2). 283–289. 43 indexed citations
13.
Grandits, Greg, Philip R. Liebson, Sinda Dianzumba, & Ronald J. Prineas. (1994). Echocardiography in multicenter clinical trials: Experience from the treatment of mild hypertension study. Controlled Clinical Trials. 15(5). 395–410. 16 indexed citations
14.
Peters, Robert W., et al.. (1993). Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: The cardiac arrhythmia suppression trial (CAST) experience. Journal of the American College of Cardiology. 22(4). 998–1003. 42 indexed citations
15.
Barron, John T., et al.. (1992). Electrocardiographic abnormalities in mitral valve prolapse. The American Journal of Cardiology. 70(2). 265–266. 15 indexed citations
16.
Echt, Debra S., Philip R. Liebson, L. Brent Mitchell, et al.. (1991). Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo. New England Journal of Medicine. 324(12). 781–788. 2127 indexed citations breakdown →
17.
Liebson, Philip R., et al.. (1989). Determination of cardiac output in critically ill patients by dual beam doppler echocardiography. Journal of the American College of Cardiology. 13(2). 340–347. 26 indexed citations
18.
Barron, John T., et al.. (1988). Comparison of auscultation with two‐dimensional and doppler echocardiography in patients with suspected mitral valve prolapse. Clinical Cardiology. 11(10). 401–6. 14 indexed citations
19.
Bharati, Saroja, et al.. (1981). The conduction system in mitral valve prolapse syndrome with sudden death. American Heart Journal. 101(5). 667–670. 85 indexed citations
20.
Meng, Ronald L., et al.. (1975). The use of noninvasive methods in the evaluation of left ventricular performance in coronary artery disease. American Heart Journal. 90(2). 134–144. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kim Fox Breakdown of academic impact, for papers by Susan J. Zieman Breakdown of academic impact, for papers by Jaap W. Deckers Breakdown of academic impact, for papers by Lars Rydén Breakdown of academic impact, for papers by Eugene R. Passamani Breakdown of academic impact, for papers by Shmuel Gottlieb Breakdown of academic impact, for papers by Bariş Gencer Breakdown of academic impact, for papers by Tomas Jernberg Breakdown of academic impact, for papers by Edward M. Geltman Breakdown of academic impact, for papers by Steen Z. Abildstrøm
Rankless by CCL
2026